Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XRF ScientificASX:XRF +0.28%96 3-Year EPS without NRI Growth Rate is 9.20% as of Jun. 2026, which is 49% below its 10-year median of 18.00. GuruFocus rates ASX:XRF with a GF Score™ of 96/100 and a GF Value™ of A$1.78 (Fairly Valued). The stock has 1 warning sign investors should review. Among 423 Conglomerates companies, XRF Scientific ranks better than 52.25% on this metric.
During the past 12 months, XRF Scientific's average EPS without NRI Growth Rate was -1.40% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 9.20% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 15.00% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 29.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of XRF Scientific was 69.10% per year. The lowest was -30.70% per year. And the median was 18.00% per year.
XRF Scientific (ASX:XRF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
XRF Scientific 3-Year EPS without NRI Growth Rate Related Terms
ASX:XRF vs MMM, HON: 3-Year EPS without NRI Growth Rate Comparison
For the Conglomerates subindustry, XRF Scientific's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific 3-Year EPS without NRI Growth Rate vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where XRF Scientific's 3-Year EPS without NRI Growth Rate falls into.
XRF Scientific 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 9.20% mean?
XRF Scientific (ASX:XRF) has a 3-Year EPS without NRI Growth Rate of 9.20% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for XRF Scientific and its competitors. This is 49% below median its historical median of 18.00. According to the industry distribution chart, XRF Scientific ranks #202 out of 423 companies in the Conglomerates industry, placing it in the top 47.8%.
Is XRF Scientific's 3-Year EPS without NRI Growth Rate too high?
XRF Scientific's current 3-Year EPS without NRI Growth Rate of 9.20% is 49% below median its 10-year median of 18.00. The Conglomerates industry median 3-Year EPS without NRI Growth Rate is 7.90. XRF Scientific's value of 9.20% is 16.5% above this industry median. Based on the distribution chart, XRF Scientific ranks #202 out of 423 companies in the Conglomerates industry, which is above the industry midpoint. Overall, XRF Scientific has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's 3-Year EPS without NRI Growth Rate compare to MMM and HON?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #202 out of 423 companies for 3-Year EPS without NRI Growth Rate. This puts XRF Scientific in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.90. XRF Scientific's value of 9.20% is 16.5% above this benchmark. While the company's 10-year median is 18.00 vs. the industry median of 7.90, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Conglomerates company?
The median 3-Year EPS without NRI Growth Rate among Conglomerates companies is 7.90, based on 423 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current 3-Year EPS without NRI Growth Rate of 9.20% is 16.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for XRF Scientific and its competitors. For the Conglomerates industry, the median 3-Year EPS without NRI Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current 3-Year EPS without NRI Growth Rate is 9.20%, which is 49% below median its own 10-year median of 18.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.78, compared to a current price of A$1.82 — trading 2% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 9.20%, which is 49% below median its 10-year median of 18.00 and 16.5% above the Conglomerates industry median of 7.90. XRF Scientific's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current 3-Year EPS without NRI Growth Rate is 9.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.82 is trading 2% above its estimated GF Value™ of A$1.78.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
3-Year EPS without NRI Growth Rate: 9.20% (49% below median its 10-year median of 18.00)
GF Value™: A$1.78 vs. price of A$1.82 (2% above fair value)
Industry Position: 16.5% above the Conglomerates median (#202 of 423)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
96GF Score
Get the complete analysis for ASX:XRF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
